Amikacin Sulfate/Fosfomycin sodium

硫酸阿米卡星/磷霉素钠

Report date: 2022/07/19 20:00:45
QIDP

Base Information

Drug NameAmikacin Sulfate/Fosfomycin sodium
Drug Alias NameAmikacin/Fosfomycin磷霉素钠/硫酸阿米卡星Fosfomycin sodium/Amikacin Sulfate
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsPneumonia, Bacterial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoTurkey +[7] 
CombinationsYes Amikacin SulfateFosfomycin sodium
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCardeas Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCardeas Pharma
Active IndicationsN/A
Inactive IndicationsPneumonia, Bacterial

Other Information

ATC CodeN/A
Related LinksN/A